Cargando…

Development of a universal dual-bolus injection scheme for the quantitative assessment of myocardial perfusion cardiovascular magnetic resonance

BACKGROUND: The dual-bolus protocol enables accurate quantification of myocardial blood flow (MBF) by first-pass perfusion cardiovascular magnetic resonance (CMR). However, despite the advantages and increasing demand for the dual-bolus method for accurate quantification of MBF, thus far, it has not...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishida, Masaki, Schuster, Andreas, Morton, Geraint, Chiribiri, Amedeo, Hussain, Shazia, Paul, Matthias, Merkle, Nico, Steen, Henning, Lossnitzer, Dirk, Schnackenburg, Bernhard, Alfakih, Khaled, Plein, Sven, Nagel, Eike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3118114/
https://www.ncbi.nlm.nih.gov/pubmed/21609423
http://dx.doi.org/10.1186/1532-429X-13-28
_version_ 1782206415954247680
author Ishida, Masaki
Schuster, Andreas
Morton, Geraint
Chiribiri, Amedeo
Hussain, Shazia
Paul, Matthias
Merkle, Nico
Steen, Henning
Lossnitzer, Dirk
Schnackenburg, Bernhard
Alfakih, Khaled
Plein, Sven
Nagel, Eike
author_facet Ishida, Masaki
Schuster, Andreas
Morton, Geraint
Chiribiri, Amedeo
Hussain, Shazia
Paul, Matthias
Merkle, Nico
Steen, Henning
Lossnitzer, Dirk
Schnackenburg, Bernhard
Alfakih, Khaled
Plein, Sven
Nagel, Eike
author_sort Ishida, Masaki
collection PubMed
description BACKGROUND: The dual-bolus protocol enables accurate quantification of myocardial blood flow (MBF) by first-pass perfusion cardiovascular magnetic resonance (CMR). However, despite the advantages and increasing demand for the dual-bolus method for accurate quantification of MBF, thus far, it has not been widely used in the field of quantitative perfusion CMR. The main reasons for this are that the setup for the dual-bolus method is complex and requires a state-of-the-art injector and there is also a lack of post processing software. As a solution to one of these problems, we have devised a universal dual-bolus injection scheme for use in a clinical setting. The purpose of this study is to show the setup and feasibility of the universal dual-bolus injection scheme. METHODS: The universal dual-bolus injection scheme was tested using multiple combinations of different contrast agents, contrast agent dose, power injectors, perfusion sequences, and CMR scanners. This included 3 different contrast agents (Gd-DO3A-butrol, Gd-DTPA and Gd-DOTA), 4 different doses (0.025 mmol/kg, 0.05 mmol/kg, 0.075 mmol/kg and 0.1 mmol/kg), 2 different types of injectors (with and without "pause" function), 5 different sequences (turbo field echo (TFE), balanced TFE, k-space and time (k-t) accelerated TFE, k-t accelerated balanced TFE, turbo fast low-angle shot) and 3 different CMR scanners from 2 different manufacturers. The relation between the time width of dilute contrast agent bolus curve and cardiac output was obtained to determine the optimal predefined pause duration between dilute and neat contrast agent injection. RESULTS: 161 dual-bolus perfusion scans were performed. Three non-injector-related technical errors were observed (1.9%). No injector-related errors were observed. The dual-bolus scheme worked well in all the combinations of parameters if the optimal predefined pause was used. Linear regression analysis showed that the optimal duration for the predefined pause is 25s to separate the dilute and neat contrast agent bolus curves if 0.1 mmol/kg dose of Gd-DO3A-butrol is used. CONCLUSION: The universal dual-bolus injection scheme does not require sophisticated double-head power injector function and is a feasible technique to obtain reasonable arterial input function curves for absolute MBF quantification.
format Online
Article
Text
id pubmed-3118114
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31181142011-06-19 Development of a universal dual-bolus injection scheme for the quantitative assessment of myocardial perfusion cardiovascular magnetic resonance Ishida, Masaki Schuster, Andreas Morton, Geraint Chiribiri, Amedeo Hussain, Shazia Paul, Matthias Merkle, Nico Steen, Henning Lossnitzer, Dirk Schnackenburg, Bernhard Alfakih, Khaled Plein, Sven Nagel, Eike J Cardiovasc Magn Reson Technical Notes BACKGROUND: The dual-bolus protocol enables accurate quantification of myocardial blood flow (MBF) by first-pass perfusion cardiovascular magnetic resonance (CMR). However, despite the advantages and increasing demand for the dual-bolus method for accurate quantification of MBF, thus far, it has not been widely used in the field of quantitative perfusion CMR. The main reasons for this are that the setup for the dual-bolus method is complex and requires a state-of-the-art injector and there is also a lack of post processing software. As a solution to one of these problems, we have devised a universal dual-bolus injection scheme for use in a clinical setting. The purpose of this study is to show the setup and feasibility of the universal dual-bolus injection scheme. METHODS: The universal dual-bolus injection scheme was tested using multiple combinations of different contrast agents, contrast agent dose, power injectors, perfusion sequences, and CMR scanners. This included 3 different contrast agents (Gd-DO3A-butrol, Gd-DTPA and Gd-DOTA), 4 different doses (0.025 mmol/kg, 0.05 mmol/kg, 0.075 mmol/kg and 0.1 mmol/kg), 2 different types of injectors (with and without "pause" function), 5 different sequences (turbo field echo (TFE), balanced TFE, k-space and time (k-t) accelerated TFE, k-t accelerated balanced TFE, turbo fast low-angle shot) and 3 different CMR scanners from 2 different manufacturers. The relation between the time width of dilute contrast agent bolus curve and cardiac output was obtained to determine the optimal predefined pause duration between dilute and neat contrast agent injection. RESULTS: 161 dual-bolus perfusion scans were performed. Three non-injector-related technical errors were observed (1.9%). No injector-related errors were observed. The dual-bolus scheme worked well in all the combinations of parameters if the optimal predefined pause was used. Linear regression analysis showed that the optimal duration for the predefined pause is 25s to separate the dilute and neat contrast agent bolus curves if 0.1 mmol/kg dose of Gd-DO3A-butrol is used. CONCLUSION: The universal dual-bolus injection scheme does not require sophisticated double-head power injector function and is a feasible technique to obtain reasonable arterial input function curves for absolute MBF quantification. BioMed Central 2011-05-24 /pmc/articles/PMC3118114/ /pubmed/21609423 http://dx.doi.org/10.1186/1532-429X-13-28 Text en Copyright ©2011 Ishida et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Technical Notes
Ishida, Masaki
Schuster, Andreas
Morton, Geraint
Chiribiri, Amedeo
Hussain, Shazia
Paul, Matthias
Merkle, Nico
Steen, Henning
Lossnitzer, Dirk
Schnackenburg, Bernhard
Alfakih, Khaled
Plein, Sven
Nagel, Eike
Development of a universal dual-bolus injection scheme for the quantitative assessment of myocardial perfusion cardiovascular magnetic resonance
title Development of a universal dual-bolus injection scheme for the quantitative assessment of myocardial perfusion cardiovascular magnetic resonance
title_full Development of a universal dual-bolus injection scheme for the quantitative assessment of myocardial perfusion cardiovascular magnetic resonance
title_fullStr Development of a universal dual-bolus injection scheme for the quantitative assessment of myocardial perfusion cardiovascular magnetic resonance
title_full_unstemmed Development of a universal dual-bolus injection scheme for the quantitative assessment of myocardial perfusion cardiovascular magnetic resonance
title_short Development of a universal dual-bolus injection scheme for the quantitative assessment of myocardial perfusion cardiovascular magnetic resonance
title_sort development of a universal dual-bolus injection scheme for the quantitative assessment of myocardial perfusion cardiovascular magnetic resonance
topic Technical Notes
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3118114/
https://www.ncbi.nlm.nih.gov/pubmed/21609423
http://dx.doi.org/10.1186/1532-429X-13-28
work_keys_str_mv AT ishidamasaki developmentofauniversaldualbolusinjectionschemeforthequantitativeassessmentofmyocardialperfusioncardiovascularmagneticresonance
AT schusterandreas developmentofauniversaldualbolusinjectionschemeforthequantitativeassessmentofmyocardialperfusioncardiovascularmagneticresonance
AT mortongeraint developmentofauniversaldualbolusinjectionschemeforthequantitativeassessmentofmyocardialperfusioncardiovascularmagneticresonance
AT chiribiriamedeo developmentofauniversaldualbolusinjectionschemeforthequantitativeassessmentofmyocardialperfusioncardiovascularmagneticresonance
AT hussainshazia developmentofauniversaldualbolusinjectionschemeforthequantitativeassessmentofmyocardialperfusioncardiovascularmagneticresonance
AT paulmatthias developmentofauniversaldualbolusinjectionschemeforthequantitativeassessmentofmyocardialperfusioncardiovascularmagneticresonance
AT merklenico developmentofauniversaldualbolusinjectionschemeforthequantitativeassessmentofmyocardialperfusioncardiovascularmagneticresonance
AT steenhenning developmentofauniversaldualbolusinjectionschemeforthequantitativeassessmentofmyocardialperfusioncardiovascularmagneticresonance
AT lossnitzerdirk developmentofauniversaldualbolusinjectionschemeforthequantitativeassessmentofmyocardialperfusioncardiovascularmagneticresonance
AT schnackenburgbernhard developmentofauniversaldualbolusinjectionschemeforthequantitativeassessmentofmyocardialperfusioncardiovascularmagneticresonance
AT alfakihkhaled developmentofauniversaldualbolusinjectionschemeforthequantitativeassessmentofmyocardialperfusioncardiovascularmagneticresonance
AT pleinsven developmentofauniversaldualbolusinjectionschemeforthequantitativeassessmentofmyocardialperfusioncardiovascularmagneticresonance
AT nageleike developmentofauniversaldualbolusinjectionschemeforthequantitativeassessmentofmyocardialperfusioncardiovascularmagneticresonance